Ignite Creation Date:
2024-05-06 @ 5:39 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05387707
Status:
TERMINATED
Last Update Posted:
2024-02-22
First Post:
2022-05-19
Brief Title:
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
Sponsor:
Cara Therapeutics Inc
Organization:
Cara Therapeutics Inc
Organization Data
Organization:
Cara Therapeutics Inc
Class:
INDUSTRY
Study ID:
CR845-310501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cara Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None